Advanced search
Publication Cover
Journal of Liposome Research Volume 11, 2001 - Issue 2-3
Submit an article Journal homepage
31
Views
3
CrossRef citations to date
0
Altmetric
Research Article

EVALUATING THE EFFICACY OF AMIKACIN IN LOW-CLEARANCE UNILAMELLAR LIPOSOMES IN A S. AUREUS LOCAL INFECTION MODEL

Augusta E. Garrison Gilead Sciences, Inc., 2860 Wilderness Place, Boulder, CO, 80301, U.S.A.
,
Ray Bendele Gilead Sciences, Inc., 2860 Wilderness Place, Boulder, CO, 80301, U.S.A.
,
Susan Knauer Gilead Sciences, Inc., 2860 Wilderness Place, Boulder, CO, 80301, U.S.A.
,
Julie Wolf Gilead Sciences, Inc., 2860 Wilderness Place, Boulder, CO, 80301, U.S.A.
,
Lotus Moon-McDermott Gilead Sciences, Inc., 2860 Wilderness Place, Boulder, CO, 80301, U.S.A.
,
Stan Gill Gilead Sciences, Inc., 2860 Wilderness Place, Boulder, CO, 80301, U.S.A.
&
Dorothy B. Colagiovanni Gilead Sciences, Inc., 2860 Wilderness Place, Boulder, CO, 80301, U.S.A.
 show all
Pages 243-254 | Published online: 30 Sep 2001

REFERENCES

  • Thestrup-Pedersen K. Bacteria and the Skin: Clinical Practice and Therapy Update. Brit. Journ. Dermatol. 1998; 139: 1–3
  • Barg N. Comparison of Four Antibiotics in a Murine Model of Necrotizing Cutaneous Infections caused by Toxigenic Streptococcus pyogenes and Staphylococcus aureus. J. Antimicrob. Chemother. 1998; 42: 257–260
  • Veien N. K. The Clinician's Choice of Antibiotics in the Treatment of Bacterial Skin Infection. Brit. Journ. Dermatol. 1998; 139: 30–36
  • Yao J. D.C., Moellering R. C. Antibacterial Agents. Manual of Clinical Microbiology, P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, R. H. Yolken. Seventh Edition, American Society for Microbiology, Washington, D.C. 1999; 1474–1481
  • Edson R. S., Terrell C. L. The Aminoglycosides. Mayo Clin. Proc. 1991; 66: 1158–1164
  • Lacy M. K., Nicolau D. P., Nightingale C. H., Quintiliani R. The Pharmacodynamics of Aminoglycosides. Clin. Infect. Dis. 1998; 27: 23–27
  • Fielding R. M., Mukwaya G., Sandhaus R. A. Clinical and Preclinical Studies with Low-clearance Liposomal Amikacin (L-AN®). Long-circulating Liposomes: Old Drugs, New Therapeutics, M. C. Woodle, G. Storm. Springer-Verlag and Landes Bioscience, Austin, TX 1998; 213–225
  • Fielding R. M, Lewis R. O., Moon-McDermott L. Altered Tissue Distribution and Elimination of Amikacin Encapsulated in Unilamellar, Low-clearance Liposomes (MiKasome®). Pharmacol Res. 1998; 15: 1775–1781
  • Xiong Y-Q., Kupferwasser L. I., Zack P. M., Bayer A. S. Comparative Efficacies of Liposomal Amikacin (MiKasome) plus Oxacillin Versus Conventional Amikacin plus Oxacillin in Experimental Endocarditis induced by Staphylococcus aureus: Microbiological and Echocardiographic Analyses. Antimicrob. Agents Chemother. 1999; 42: 1737–1742
  • Bakker-Woudenberg I. A. J. M., Lokerse A. F., ten Kate M. T., Woodle J. W., Storm G. Liposomes with Prolonged Blood Circulation and Selective Localization in Klebsiella pneumoniae-infected Lung Tissue. J. Infect. Dis. 1993; 168: 164–171
  • Chu C-J., Mahmoudi M., Olson J., Adler-Moore J. P. The 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society of Microbiology, Washington, D.C., Sept, 1997, F-39
  • Sharar S. R., Winn R. K., Murray C. E., Harlan J. M., Rice C. L. A CD18 Monoclonal Antibody Increases the Incidence and Severity of Subcutaneous Abscess Formation after High Dose S. aureus Injection in Rabbits. Surgery 1991; 110: 213
  • NCCLS. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically. Fourth Edition, NCCLS, Wayne, PA 1997, Approved Standard. NCCLS document M7-A4
  • Colagiovanni D. B., Shopp G. Evaluation of IL-1ra and TNF-bp in a Rodent Abscess Model of Host Resistance. Immunopharm. & Immunotox. 1996; 18(3)397–419
  • Drugeon H., Le Gallou F., Caillon J. Methods d'Etudes de l'Activite Bactericide. Bactericidie: Aspects Theoriques et Therapeutiques, H. Corvalin, Drugeon H., Flandrou P. J., Goldstein F. Maloine, Paris 1990; 112–126
  • Omri A., Ravaoarinoro M. Comparison of the Bacteridical Action of Amikacin, Netilmicin and Tobramycin in Free and Liposomal Formulation against Pseudomonas aeruginosa. Chemotherapy 1996; 42: 170–176
  • Drusano G. L. Role of Pharmacokinetics in the Outcome of Infections. Antimicrob. Agents Chemother. 1988; 32: 289–297
  • Craig W. A., Redington J., Ebert S. C. Pharmacodynamics of Amikacin in vitro and in Mouse Thigh and Lung Infection. J Antimic Chemo. 1991; 27(Suppl C)29–40
  • Gillette W., Wolf J., Allen R., Moon-McDermott L., Gill S. C., Colagiovanni D. B. The 40thInterscience Conference on Antimicrobial Agents and Chemotherapy. American Society of Microbiology, TorontoCanada, Sept, 2000, #2255
  • Bearden D. T., Rodvold K. A. Penetration of Macrolides into Pulmonary Sites of Infection. Infect. Med. 1999; 16: 480–484A

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.